Literature DB >> 14638517

In vitro susceptibility testing of Geotrichum capitatum: comparison of the E-test, disk diffusion, and Sensititre colorimetric methods with the NCCLS M27-A2 broth microdilution reference method.

C Girmenia1, G Pizzarelli, D D'Antonio, F Cristini, P Martino.   

Abstract

The in vitro activities of amphotericin B, flucytosine, fluconazole, itraconazole, and voriconazole against 23 isolates of Geotrichum capitatum were determined by the National Committee for Clinical Laboratory Standards (NCCLS) M27-A2 microdilution method and the Sensititre and agar diffusion methods. Amphotericin B and voriconazole appeared to be the more active drugs. Sensititre showed the highest rates of agreement with the NCCLS M27-A2 method.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14638517      PMCID： PMC296229          DOI： 10.1128/AAC.47.12.3985-3988.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole.

Authors:  Madonna J Matar; Luis Ostrosky-Zeichner; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

2.  In-vitro comparative activity of fluconazole and other antifungal agents against Blastoschizomyces capitatus.

Authors:  M Venditti; B Posteraro; G Morace; P Martino
Journal:  J Chemother       Date:  1991-02       Impact factor: 1.714

3.  Emergence of fluconazole-resistant strains of Blastoschizomyces capitatus causing nosocomial infections in cancer patients.

Authors:  D D'Antonio; A Mazzoni; A Iacone; B Violante; M A Capuani; F Schioppa; F Romano
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

4.  Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001.

Authors:  M A Pfaller; D J Diekema; S A Messer; L Boyken; R J Hollis
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

5.  Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients.

Authors:  P Martino; M Venditti; A Micozzi; G Morace; L Polonelli; M P Mantovani; M C Petti; V L Burgio; C Santini; P Serra
Journal:  Rev Infect Dis       Date:  1990 Jul-Aug

6.  In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.

Authors:  M A Pfaller; S A Messer; R J Hollis; R N Jones; D J Diekema
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

7.  Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods.

Authors:  A L Barry; M A Pfaller; R P Rennie; P C Fuchs; S D Brown
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

8.  Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species.

Authors:  G Morace; G Amato; F Bistoni; G Fadda; P Marone; M T Montagna; S Oliveri; L Polonelli; R Rigoli; I Mancuso; S La Face; L Masucci; L Romano; C Napoli; D Tatò; M G Buscema; C M C Belli; M M Piccirillo; S Conti; S Covan; F Fanti; C Cavanna; F D'Alò; L Pitzurra
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

9.  Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review.

Authors:  E Anaissie; A Gokaslan; R Hachem; R Rubin; G Griffin; R Robinson; J Sobel; G Bodey
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

10.  Fluconazole treatment of Blastoschizomyces capitatus meningitis in an allogeneic bone marrow recipient.

Authors:  C Girmenia; A Micozzi; M Venditti; G Meloni; A P Iori; S Bastianello; P Martino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-09       Impact factor: 3.267
View more
  10 in total

Review 1.  Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 2.  Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature.

Authors:  Corrado Girmenia; Livio Pagano; Bruno Martino; Domenico D'Antonio; Rosa Fanci; Giorgina Specchia; Lorella Melillo; Massimo Buelli; Giampaolo Pizzarelli; Mario Venditti; Pietro Martino
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

3.  Efficacy of Posaconazole in a Murine Model of Systemic Infection by Saprochaete capitata.

Authors:  Pamela Thomson; Josep Guarro; Emilio Mayayo; Javier Capilla
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

4.  Pan-azole-resistant Candida guilliermondii from a leukemia patient's silent funguria.

Authors:  Vincenzo Savini; Chiara Catavitello; Ilaria Di Marzio; Gioviana Masciarelli; Daniela Astolfi; Andrea Balbinot; Azaira Bianco; Arianna Pompilio; Giovanni Di Bonaventura; Claudio D'Amario; Domenico D'Antonio
Journal:  Mycopathologia       Date:  2010-02-05       Impact factor: 2.574

5.  Molecular Diagnostics of Arthroconidial Yeasts, Frequent Pulmonary Opportunists.

Authors:  Engin Kaplan; Abdullah M S Al-Hatmi; Macit Ilkit; A H G Gerrits van den Ende; Ferry Hagen; Jacques F Meis; G Sybren de Hoog
Journal:  J Clin Microbiol       Date:  2017-12-26       Impact factor: 5.948

6.  A Case of Magnusiomyces capitatus Peritonitis Without Underlying Malignancies.

Authors:  Carlos D'Assumpcao; Benson Lee; Arash Heidari
Journal:  J Investig Med High Impact Case Rep       Date:  2018-08-21

7.  Bloodstream Infections Caused by Magnusiomyces capitatus and Magnusiomyces clavatus: Epidemiological, Clinical, and Microbiological Features of Two Emerging Yeast Species.

Authors:  Janina Noster; Martin B Koeppel; Marie Desnos-Olivier; Maria Aigner; Oliver Bader; Karl Dichtl; Stephan Göttig; Andrea Haas; Oliver Kurzai; Arthur B Pranada; Yvonne Stelzer; Grit Walther; Axel Hamprecht
Journal:  Antimicrob Agents Chemother       Date:  2021-12-20       Impact factor: 5.191

8.  Voriconazole in the management of nosocomial invasive fungal infections.

Authors:  Javier Pemán; Miguel Salavert; Emilia Cantón; Isidro Jarque; Eva Romá; Rafael Zaragoza; Angel Viudes; Miguel Gobernado
Journal:  Ther Clin Risk Manag       Date:  2006-06       Impact factor: 2.423

9.  Isavuconazole Therapy of Disseminated and Encephalic Saprochaete Capitata Infection in an Acute Myeloid Leukemia Patient Treated with Midostaurin.

Authors:  Salvatore Perrone; Chiara Lisi; Elettra Ortu La Barbera; Cristina Luise; Miriam Lichtner; Corrado Girmenia; Giuseppe Cimino
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-05-01       Impact factor: 2.576

10.  Disseminated Saprochaete capitata fungal infection in a patient with acute myeloid leukemia.

Authors:  Delfim Duarte; Cátia Iracema Morais; Rosa Azevedo; Fernando Coelho; Anabela Martins; Brigitte Pereira; Sara Coelho; Nelson Domingues; Ana Lebre; Filipe Trigo; Iracema Romero; Maria Augusta Guimarães; José Mário Mariz; Filomena Faria
Journal:  Clin Case Rep       Date:  2021-02-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.